Market cap
₹523 Cr
Recently Viewed
Clear AllNSE: KRONOX | BSE: 544187
₹140.62
₹5.39
(3.99%)
As on 30-Apr-2026IST
Market cap
₹523 Cr
Revenue (TTM)
₹101 Cr
P/E Ratio
20.2
P/B Ratio
4.8
Div. Yield
0.4 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹26 Cr
ROE
32.6 %
ROCE
43.8 %
Industry P/E
36.56
EV/EBITDA
14.1
Debt to Equity
0
Book Value
₹29.1
EPS
₹7
Face value
10
Shares outstanding
37,104,000
CFO
₹88.11 Cr
EBITDA
₹117.65 Cr
Net Profit
₹86.58 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kronox Lab Sciences
| 0.6 | 38.0 | 15.0 | -0.9 | -- | -- | -- |
|
BSE Commodities
| 5.9 | 14.4 | 3.4 | 16.1 | 17.4 | 12.1 | 16.1 |
|
Company
|
2025
|
|---|---|
|
Kronox Lab Sciences
| -31.8 |
|
BSE Small Cap
| -6.6 |
|
BSE Commodities
| 12.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kronox Lab Sciences
|
140.6 | 522.6 | 101.2 | 25.9 | 30.3 | 27 | 20.2 | 4.8 |
| 507.5 | 18,390.8 | 8,045.0 | 378.0 | 7.8 | 6.6 | 48.7 | 3.1 | |
| 1,171.8 | 15,561.4 | 1,088.6 | 215.8 | 27.4 | 9.8 | 72.1 | 6.5 | |
| 1,343.8 | 15,190.8 | 2,229.8 | 229.1 | 18.1 | 5.7 | 88.3 | 4.7 | |
| 1,736.9 | 23,690.1 | 7,946.4 | 533.3 | 8.9 | 9.9 | 44.4 | 4.2 | |
| 4,628.1 | 14,183.3 | 2,347.3 | 398.8 | 17.9 | 16.4 | 35.8 | 5.6 | |
| 3,999.0 | 9,252.2 | 2,071.4 | 307.8 | 17.4 | 12.6 | 30.1 | 3.6 | |
| 713.8 | 11,360.7 | 4,260.9 | 265.7 | 9.0 | 9.2 | 42.8 | 3.7 | |
| 3,360.1 | 13,110.0 | 2,455.7 | 286.6 | 18.6 | 25.6 | 43.6 | 10.0 | |
| 1,322.3 | 13,708.7 | 2,271.4 | 442.9 | 24.7 | 15.5 | 30.9 | 4.5 |
4 min read•By Hemkesh Khattar
--
Incorporated
2008
Chairman
Jogindersingh Jaswal
Managing Director
Jogindersingh Jaswal
Headquarters
Vadodara, Gujarat
Website
Looking for more details about Kronox Lab Sciences Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
The share price of Kronox Lab Sciences Ltd is ₹140.62 (NSE) and ₹140.84 (BSE) as of 30-Apr-2026 IST. Kronox Lab Sciences Ltd has given a return of -0.94% in the last 1 years.
The P/E ratio of Kronox Lab Sciences Ltd is 20.21 times as on 30-Apr-2026, a 45 discount to its peers’ median range of 36.56 times.
The P/B ratio of Kronox Lab Sciences Ltd is 4.84 times as on 30-Apr-2026, a 98 premium to its peers’ median range of 2.45 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
20.96
|
5.92
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Kronox Lab Sciences Ltd are Rs 207.49 and Rs 96.00 as of 30-Apr-2026.
Kronox Lab Sciences Ltd has a market capitalisation of ₹ 523 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Kronox Lab Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.